Assisted Reproductive Technology Market (By Product: Instrument, Accessory & Disposable, Reagents & media; By Technology: In-Vitro Fertilization, Artificial Insemination; By Diagnosis: Ovulation Testing, Hysterosalpingography; By End-User: Ambulatory surgical centers, Hospitals, Clinics, Diagnostic centers, Gynecology Centers, Feminist Health Centers, IVF Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
The global assisted reproductive technology market size was exhibited at USD 26.34 billion in 2022 and is projected to be worth around USD 66.77 billion by 2032 with an increasing CAGR of 9.8% during the forecast period 2023 to 2032.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
Assisted reproductive technology is carried out in medical centers. With the increased growth of infertility and enhance assisted reproductive technology. Assisted reproductive technology is fertility treatment. Which involved medical treatment, for example, in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), cryopreservation of gametes or embryos, or fertility treatment including medications for gaining fertility. Assisted reproductive technology is majorly involved in reproductive endocrinology and infertility.
Assisted reproductive technology is also involved in surrogacy treatment but cannot be used in every surrogacy treatment. Infertility issues can be solved using assisted reproductive technology with the conventional method of treating infertility with enhanced sterility. The advanced technologies developed in the market for treating infertility problems with increasing research and development help to grow the market of assisted reproductive technology with an enhanced growth rate during the forecast period.
Impact of Covid-19 on assisted reproductive technology with a negative effect on the market with reduced patients visiting the health care centres at a reduced market rate due to fewer demands. Post-pandemic impact of covid-19 on the assisted reproductive technology market with enhanced growth rate and enhanced consultation and treatment involved in infertility helps to boost the market of assisted reproductive technology.
Report Coverage | Details |
Market Size in 2023 | USD 28.79 Billion |
Market Size by 2032 | USD 66.77 Billion |
Growth Rate from 2023 to 2032 | CAGR of 9.8% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Segments Covered |
|
Regions Covered |
|
Enhance the growth of assisted reproductive technology with increasing rates of infertility rate due to Sexually Transmitted Infections, increased smoking, increasing obesity, endometriosis, Polycystic Ovary Syndrome, Primary Ovary Insufficiency, and others. With the increase in demands from the customer to gain fertility from various technology developed and to drive the market of assisted reproductive technology.
The rise in acceptance of the developed technology by the market enhances the efficiency of the treatment or medication involved in treating infertility problems. Developed technologies such as Preimplantation Genetic Testing, Magnetic Activates Cell Sorting, and many more. Increasing awareness regarding the advance developed technology in infertility treatment help to propel the market of assisted reproductive technology with an enhanced growth rate during the forecast period.
The number of an organization participating in an increased number of treatments involved for treating infertility may help to boost the market of assisted reproductive technology. Government support for increasing the advanced technologies in assisted reproductive technology with increased integration of the technologies in the health care sector with enhanced developed technology help to grow the market of assisted reproductive technology. Increased government investment from various regions helps to grow the market with increased revenue share.
Key Market Drivers
Key Market Challenges
The increased cost of assisted reproductive technology
Lack of skill among the people
The increasing availability of options
Key Market Opportunities
Emerging regions with enhanced development
Increased support from the government
On the basis of product segmentation of assisted reproductive technology, the accessory & disposable market with largest market share with increasing demands from the medical center for the developed technologies in infertility problems. Increasing infertility prevalence among women and enhanced demands for fertilization techniques developed.
Increasing the number of screening of the sperms, analysis, and gametes handling techniques with an increasing number of treatments and enhancing the technologies with new techniques and help to drive the market of assisted reproductive technology. Reagents and media also with significant growth of the technology with enhanced demands for embryo transfer and increasing In Vitro Fertilization and enhance the market growth.
On the basis of technology in segmentation of the assisted reproductive technology, In - Vitro Fertilization accounts for the largest market growth in assisted reproductive technology. This helps to enhance the market rate with increasing demands from the medical sector for new technologies with increasing efficiency of the treatment and solving the infertility problem and enhance the fertility rate among the women with various medications and treatments developed in the assisted reproductive technology.
Moreover, artificial insemination also with the highest market growth with increasing CAGR and improving infrastructure may extend the market to a larger extent during the forecast period.
On the basis of end-user in segmentation of the assisted reproductive technology, the fertility clinic segment account for the fastest growing segment with the increasing prevalence of infertility disorder among women due to changing lifestyle, changing dietary intake, increased obesity, lack of exercise may be led to increase infertility and enhance demands for the treatment and medications for increasing the fertility with increasing the efficiency of the treatment.
The surgical center also growing with increasing demands and growing the market growth rate of assisted reproductive technology to a larger extent during the forecast period.
Assisted Reproductive Technology Market Share, By Region, 2022 (%)
Regions | Revenue Share in 2022 (%) |
North America | 26% |
Asia Pacific | 30% |
Europe | 37.8% |
Latin America | 4% |
MEA | 2.2% |
On the basis of geography in segmentation of the assisted reproductive technology, the Asia Pacific region dominates the market of assisted reproductive technology with increased developments and increase in research and development with enhanced investment from the government with increased technologies and infrastructure in the health care sectors. Increasing disposable with enhanced utilization of the health care center due to infertility problems rising among women.
Europe also with significant growth in assisted reproductive technology with increasing interest from the market players in developing technologies for treating infertility. North America, the Middle East, and Africa in the process to contribute for increasing the growth rate of assisted reproductive technology during the forecast period.
Key Market Players Insights
The key market players involved in the introduction of the newly developed technology in assisted reproductive technology with increasing efficiency of the treatment help to rise the market with increasing demands from patients with enhanced infertility. A large number of investments done by the key market players for introducing new technology and constant research and development in assisted reproductive technology. Which accelerates the market of assisted reproductive technology with a rising rate during the forecast period.
Segments Covered in the Report
By Product
By Technology
By Diagnosis
By End-User
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Assisted Reproductive Technology Market
5.1. COVID-19 Landscape: Assisted Reproductive Technology Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Assisted Reproductive Technology Market, By Product
8.1. Assisted Reproductive Technology Market, by Product, 2023-2032
8.1.1. Instrument
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. Accessory & Disposable
8.1.2.1. Market Revenue and Forecast (2021-2032)
8.1.3. Reagents & media
8.1.3.1. Market Revenue and Forecast (2021-2032)
Chapter 9. Global Assisted Reproductive Technology Market, By Technology
9.1. Assisted Reproductive Technology Market, by Technology, 2023-2032
9.1.1. In-Vitro Fertilization (IVF)
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Artificial Insemination
9.1.2.1. Market Revenue and Forecast (2021-2032)
Chapter 10. Global Assisted Reproductive Technology Market, By Diagnosis
10.1. Assisted Reproductive Technology Market, by Diagnosis, 2023-2032
10.1.1. Ovulation Testing
10.1.1.1. Market Revenue and Forecast (2021-2032)
10.1.2. Hysterosalpingography
10.1.2.1. Market Revenue and Forecast (2021-2032)
Chapter 11. Global Assisted Reproductive Technology Market, By End-User
11.1. Assisted Reproductive Technology Market, by End-User, 2023-2032
11.1.1. Ambulatory surgical centers
11.1.1.1. Market Revenue and Forecast (2021-2032)
11.1.2. Hospitals
11.1.2.1. Market Revenue and Forecast (2021-2032)
11.1.3. Clinics
11.1.3.1. Market Revenue and Forecast (2021-2032)
11.1.4. Diagnostic centers
11.1.4.1. Market Revenue and Forecast (2021-2032)
11.1.5. Gynecology Centers
11.1.5.1. Market Revenue and Forecast (2021-2032)
11.1.6. Feminist Health Centers
11.1.6.1. Market Revenue and Forecast (2021-2032)
11.1.7. IVF Centers
11.1.7.1. Market Revenue and Forecast (2021-2032)
Chapter 12. Global Assisted Reproductive Technology Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2021-2032)
12.1.2. Market Revenue and Forecast, by Technology (2021-2032)
12.1.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.1.4. Market Revenue and Forecast, by End-User (2021-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2021-2032)
12.1.5.2. Market Revenue and Forecast, by Technology (2021-2032)
12.1.5.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.1.5.4. Market Revenue and Forecast, by End-User (2021-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2021-2032)
12.1.6.2. Market Revenue and Forecast, by Technology (2021-2032)
12.1.6.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.1.6.4. Market Revenue and Forecast, by End-User (2021-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2021-2032)
12.2.2. Market Revenue and Forecast, by Technology (2021-2032)
12.2.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.2.4. Market Revenue and Forecast, by End-User (2021-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2021-2032)
12.2.5.2. Market Revenue and Forecast, by Technology (2021-2032)
12.2.5.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.2.5.4. Market Revenue and Forecast, by End-User (2021-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2021-2032)
12.2.6.2. Market Revenue and Forecast, by Technology (2021-2032)
12.2.6.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.2.6.4. Market Revenue and Forecast, by End-User (2021-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2021-2032)
12.2.7.2. Market Revenue and Forecast, by Technology (2021-2032)
12.2.7.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.2.7.4. Market Revenue and Forecast, by End-User (2021-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2021-2032)
12.2.8.2. Market Revenue and Forecast, by Technology (2021-2032)
12.2.8.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.2.8.4. Market Revenue and Forecast, by End-User (2021-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2021-2032)
12.3.2. Market Revenue and Forecast, by Technology (2021-2032)
12.3.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.3.4. Market Revenue and Forecast, by End-User (2021-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2021-2032)
12.3.5.2. Market Revenue and Forecast, by Technology (2021-2032)
12.3.5.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.3.5.4. Market Revenue and Forecast, by End-User (2021-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2021-2032)
12.3.6.2. Market Revenue and Forecast, by Technology (2021-2032)
12.3.6.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.3.6.4. Market Revenue and Forecast, by End-User (2021-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2021-2032)
12.3.7.2. Market Revenue and Forecast, by Technology (2021-2032)
12.3.7.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.3.7.4. Market Revenue and Forecast, by End-User (2021-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2021-2032)
12.3.8.2. Market Revenue and Forecast, by Technology (2021-2032)
12.3.8.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.3.8.4. Market Revenue and Forecast, by End-User (2021-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2021-2032)
12.4.2. Market Revenue and Forecast, by Technology (2021-2032)
12.4.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.4.4. Market Revenue and Forecast, by End-User (2021-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2021-2032)
12.4.5.2. Market Revenue and Forecast, by Technology (2021-2032)
12.4.5.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.4.5.4. Market Revenue and Forecast, by End-User (2021-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2021-2032)
12.4.6.2. Market Revenue and Forecast, by Technology (2021-2032)
12.4.6.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.4.6.4. Market Revenue and Forecast, by End-User (2021-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2021-2032)
12.4.7.2. Market Revenue and Forecast, by Technology (2021-2032)
12.4.7.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.4.7.4. Market Revenue and Forecast, by End-User (2021-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2021-2032)
12.4.8.2. Market Revenue and Forecast, by Technology (2021-2032)
12.4.8.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.4.8.4. Market Revenue and Forecast, by End-User (2021-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2021-2032)
12.5.2. Market Revenue and Forecast, by Technology (2021-2032)
12.5.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.5.4. Market Revenue and Forecast, by End-User (2021-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2021-2032)
12.5.5.2. Market Revenue and Forecast, by Technology (2021-2032)
12.5.5.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.5.5.4. Market Revenue and Forecast, by End-User (2021-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2021-2032)
12.5.6.2. Market Revenue and Forecast, by Technology (2021-2032)
12.5.6.3. Market Revenue and Forecast, by Diagnosis (2021-2032)
12.5.6.4. Market Revenue and Forecast, by End-User (2021-2032)
Chapter 13. Company Profiles
13.1. Vitrolife AB
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Thermo Fisher Scientific, Inc
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. The Cooper Companies, Inc (Cooper Surgical Inc.)
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Progyny Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Oxford Gene Technology
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Millendo Therapeutics, Inc
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Merck KGaA (EMD Serono, Inc)
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Genera Biomedx
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Fujifilm Holdings Corporation (Irvine Scientific Sales Company)
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Cook Medical Inc
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client